Table of Content

1 Market Overview of Restless Legs Syndrome
1.1 Restless Legs Syndrome Market Overview
1.1.1 Restless Legs Syndrome Product Scope
1.1.2 Restless Legs Syndrome Market Status and Outlook
1.2 Global Restless Legs Syndrome Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Restless Legs Syndrome Market Size by Region (2018-2034)
1.4 Global Restless Legs Syndrome Historic Market Size by Region (2018-2024)
1.5 Global Restless Legs Syndrome Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Restless Legs Syndrome Market Size (2018-2034)
1.6.1 North America Restless Legs Syndrome Market Size (2018-2034)
1.6.2 Europe Restless Legs Syndrome Market Size (2018-2034)
1.6.3 Asia-Pacific Restless Legs Syndrome Market Size (2018-2034)
1.6.4 Latin America Restless Legs Syndrome Market Size (2018-2034)
1.6.5 Middle East & Africa Restless Legs Syndrome Market Size (2018-2034)
2 Restless Legs Syndrome Market by Type
2.1 Introduction
2.1.1 Pharmacological Therapy
2.1.2 Non-Pharmacological Therapy
2.2 Global Restless Legs Syndrome Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Restless Legs Syndrome Historic Market Size by Type (2018-2024)
2.2.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Restless Legs Syndrome Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Restless Legs Syndrome Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Restless Legs Syndrome Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Restless Legs Syndrome Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Restless Legs Syndrome Revenue Breakdown by Type (2018-2034)
3 Restless Legs Syndrome Market Overview by Application
3.1 Introduction
3.1.1 Below 35 Years Old
3.1.2 From 35 to 50 Years Old
3.1.3 Above 50 Years Old
3.2 Global Restless Legs Syndrome Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Restless Legs Syndrome Historic Market Size by Application (2018-2024)
3.2.2 Global Restless Legs Syndrome Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Restless Legs Syndrome Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Restless Legs Syndrome Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Restless Legs Syndrome Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Restless Legs Syndrome Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Restless Legs Syndrome Revenue Breakdown by Application (2018-2034)
4 Restless Legs Syndrome Competition Analysis by Players
4.1 Global Restless Legs Syndrome Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2022)
4.3 Date of Key Players Enter into Restless Legs Syndrome Market
4.4 Global Top Players Restless Legs Syndrome Headquarters and Area Served
4.5 Key Players Restless Legs Syndrome Product Solution and Service
4.6 Competitive Status
4.6.1 Restless Legs Syndrome Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boehringer Ingelheim GmbH
5.1.1 Boehringer Ingelheim GmbH Profile
5.1.2 Boehringer Ingelheim GmbH Main Business
5.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Products, Services and Solutions
5.1.4 Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.1.5 Boehringer Ingelheim GmbH Recent Developments
5.2 UCB SA
5.2.1 UCB SA Profile
5.2.2 UCB SA Main Business
5.2.3 UCB SA Restless Legs Syndrome Products, Services and Solutions
5.2.4 UCB SA Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.2.5 UCB SA Recent Developments
5.3 Astellas
5.3.1 Astellas Profile
5.3.2 Astellas Main Business
5.3.3 Astellas Restless Legs Syndrome Products, Services and Solutions
5.3.4 Astellas Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.3.5 Arbor Pharmaceuticals Recent Developments
5.4 Arbor Pharmaceuticals
5.4.1 Arbor Pharmaceuticals Profile
5.4.2 Arbor Pharmaceuticals Main Business
5.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Products, Services and Solutions
5.4.4 Arbor Pharmaceuticals Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.4.5 Arbor Pharmaceuticals Recent Developments
5.5 GlaxoSmithKline plc.
5.5.1 GlaxoSmithKline plc. Profile
5.5.2 GlaxoSmithKline plc. Main Business
5.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Products, Services and Solutions
5.5.4 GlaxoSmithKline plc. Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.5.5 GlaxoSmithKline plc. Recent Developments
5.6 Ligand Pharmaceuticals Incorporated
5.6.1 Ligand Pharmaceuticals Incorporated Profile
5.6.2 Ligand Pharmaceuticals Incorporated Main Business
5.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Products, Services and Solutions
5.6.4 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.6.5 Ligand Pharmaceuticals Incorporated Recent Developments
5.7 axxonis Pharma AG
5.7.1 axxonis Pharma AG Profile
5.7.2 axxonis Pharma AG Main Business
5.7.3 axxonis Pharma AG Restless Legs Syndrome Products, Services and Solutions
5.7.4 axxonis Pharma AG Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.7.5 axxonis Pharma AG Recent Developments
5.8 Kyowa Hakko Kirin Co.
5.8.1 Kyowa Hakko Kirin Co. Profile
5.8.2 Kyowa Hakko Kirin Co. Main Business
5.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Products, Services and Solutions
5.8.4 Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.8.5 Kyowa Hakko Kirin Co. Recent Developments
5.9 Jazz Pharmaceuticals, Inc.
5.9.1 Jazz Pharmaceuticals, Inc. Profile
5.9.2 Jazz Pharmaceuticals, Inc. Main Business
5.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Products, Services and Solutions
5.9.4 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.9.5 Jazz Pharmaceuticals, Inc. Recent Developments
5.10 Omeros Corporation
5.10.1 Omeros Corporation Profile
5.10.2 Omeros Corporation Main Business
5.10.3 Omeros Corporation Restless Legs Syndrome Products, Services and Solutions
5.10.4 Omeros Corporation Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.10.5 Omeros Corporation Recent Developments
5.11 Manhattan Pharmaceuticals
5.11.1 Manhattan Pharmaceuticals Profile
5.11.2 Manhattan Pharmaceuticals Main Business
5.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Products, Services and Solutions
5.11.4 Manhattan Pharmaceuticals Restless Legs Syndrome Revenue (US$ Million) & (2018-2024)
5.11.5 Manhattan Pharmaceuticals Recent Developments
6 North America
6.1 North America Restless Legs Syndrome Market Size by Country (2018-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Restless Legs Syndrome Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Restless Legs Syndrome Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Restless Legs Syndrome Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Restless Legs Syndrome Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Restless Legs Syndrome Market Dynamics
11.1 Restless Legs Syndrome Industry Trends
11.2 Restless Legs Syndrome Market Drivers
11.3 Restless Legs Syndrome Market Challenges
11.4 Restless Legs Syndrome Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Restless Legs Syndrome Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Restless Legs Syndrome Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Restless Legs Syndrome Market Size Share by Region (2018-2024)
Table 4. Global Restless Legs Syndrome Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Restless Legs Syndrome Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Restless Legs Syndrome Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Restless Legs Syndrome Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Restless Legs Syndrome Revenue Market Share by Type (2018-2024)
Table 9. Global Restless Legs Syndrome Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Restless Legs Syndrome Revenue Market Share by Type (2024-2034)
Table 11. North America Restless Legs Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Restless Legs Syndrome Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Restless Legs Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Restless Legs Syndrome Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Restless Legs Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Restless Legs Syndrome Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Restless Legs Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Restless Legs Syndrome Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Restless Legs Syndrome Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Restless Legs Syndrome Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Restless Legs Syndrome Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Restless Legs Syndrome Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Restless Legs Syndrome Revenue Market Share by Application (2018-2024)
Table 24. Global Restless Legs Syndrome Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Restless Legs Syndrome Revenue Market Share by Application (2024-2034)
Table 26. North America Restless Legs Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Restless Legs Syndrome Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Restless Legs Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Restless Legs Syndrome Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Restless Legs Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Restless Legs Syndrome Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Restless Legs Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Restless Legs Syndrome Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Restless Legs Syndrome Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Restless Legs Syndrome Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Restless Legs Syndrome Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Restless Legs Syndrome Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2022)
Table 39. Date of Key Players Enter into Restless Legs Syndrome Market
Table 40. Global Restless Legs Syndrome Key Players Headquarters and Area Served
Table 41. Restless Legs Syndrome Product Solution and Service
Table 42. Global Restless Legs Syndrome Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Boehringer Ingelheim GmbH Basic Information List
Table 45. Boehringer Ingelheim GmbH Description and Business Overview
Table 46. Boehringer Ingelheim GmbH Restless Legs Syndrome Products, Services and Solutions
Table 47. Revenue (US$ Million) in Restless Legs Syndrome Business of Boehringer Ingelheim GmbH (2018-2024)
Table 48. Boehringer Ingelheim GmbH Recent Developments
Table 49. UCB SA Basic Information List
Table 50. UCB SA Description and Business Overview
Table 51. UCB SA Restless Legs Syndrome Products, Services and Solutions
Table 52. Revenue (US$ Million) in Restless Legs Syndrome Business of UCB SA (2018-2024)
Table 53. UCB SA Recent Developments
Table 54. Astellas Basic Information List
Table 55. Astellas Description and Business Overview
Table 56. Astellas Restless Legs Syndrome Products, Services and Solutions
Table 57. Revenue (US$ Million) in Restless Legs Syndrome Business of Astellas (2018-2024)
Table 58. Astellas Recent Developments
Table 59. Arbor Pharmaceuticals Basic Information List
Table 60. Arbor Pharmaceuticals Description and Business Overview
Table 61. Arbor Pharmaceuticals Restless Legs Syndrome Products, Services and Solutions
Table 62. Revenue (US$ Million) in Restless Legs Syndrome Business of Arbor Pharmaceuticals (2018-2024)
Table 63. Arbor Pharmaceuticals Recent Developments
Table 64. GlaxoSmithKline plc. Basic Information List
Table 65. GlaxoSmithKline plc. Description and Business Overview
Table 66. GlaxoSmithKline plc. Restless Legs Syndrome Products, Services and Solutions
Table 67. Revenue (US$ Million) in Restless Legs Syndrome Business of GlaxoSmithKline plc. (2018-2024)
Table 68. GlaxoSmithKline plc. Recent Developments
Table 69. Ligand Pharmaceuticals Incorporated Basic Information List
Table 70. Ligand Pharmaceuticals Incorporated Description and Business Overview
Table 71. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Products, Services and Solutions
Table 72. Revenue (US$ Million) in Restless Legs Syndrome Business of Ligand Pharmaceuticals Incorporated (2018-2024)
Table 73. Ligand Pharmaceuticals Incorporated Recent Developments
Table 74. axxonis Pharma AG Basic Information List
Table 75. axxonis Pharma AG Description and Business Overview
Table 76. axxonis Pharma AG Restless Legs Syndrome Products, Services and Solutions
Table 77. Revenue (US$ Million) in Restless Legs Syndrome Business of axxonis Pharma AG (2018-2024)
Table 78. axxonis Pharma AG Recent Developments
Table 79. Kyowa Hakko Kirin Co. Basic Information List
Table 80. Kyowa Hakko Kirin Co. Description and Business Overview
Table 81. Kyowa Hakko Kirin Co. Restless Legs Syndrome Products, Services and Solutions
Table 82. Revenue (US$ Million) in Restless Legs Syndrome Business of Kyowa Hakko Kirin Co. (2018-2024)
Table 83. Kyowa Hakko Kirin Co. Recent Developments
Table 84. Jazz Pharmaceuticals, Inc. Basic Information List
Table 85. Jazz Pharmaceuticals, Inc. Description and Business Overview
Table 86. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Products, Services and Solutions
Table 87. Revenue (US$ Million) in Restless Legs Syndrome Business of Jazz Pharmaceuticals, Inc. (2018-2024)
Table 88. Jazz Pharmaceuticals, Inc. Recent Developments
Table 89. Omeros Corporation Basic Information List
Table 90. Omeros Corporation Description and Business Overview
Table 91. Omeros Corporation Restless Legs Syndrome Products, Services and Solutions
Table 92. Revenue (US$ Million) in Restless Legs Syndrome Business of Omeros Corporation (2018-2024)
Table 93. Omeros Corporation Recent Developments
Table 94. Manhattan Pharmaceuticals Basic Information List
Table 95. Manhattan Pharmaceuticals Description and Business Overview
Table 96. Manhattan Pharmaceuticals Restless Legs Syndrome Products, Services and Solutions
Table 97. Revenue (US$ Million) in Restless Legs Syndrome Business of Manhattan Pharmaceuticals (2018-2024)
Table 98. Manhattan Pharmaceuticals Recent Developments
Table 99. North America Restless Legs Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 100. North America Restless Legs Syndrome Market Size by Country (2024-2034) & (US$ Million)
Table 101. Europe Restless Legs Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 102. Europe Restless Legs Syndrome Market Size by Country (2024-2034) & (US$ Million)
Table 103. Asia-Pacific Restless Legs Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 104. Asia-Pacific Restless Legs Syndrome Market Size by Region (2018-2024) & (US$ Million)
Table 105. Asia-Pacific Restless Legs Syndrome Market Size by Region (2024-2034) & (US$ Million)
Table 106. Asia-Pacific Restless Legs Syndrome Market Share by Region (2018-2024)
Table 107. Asia-Pacific Restless Legs Syndrome Market Share by Region (2024-2034)
Table 108. Latin America Restless Legs Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 109. Latin America Restless Legs Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 110. Latin America Restless Legs Syndrome Market Size by Country (2024-2034) & (US$ Million)
Table 111. Middle East & Africa Restless Legs Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 112. Middle East & Africa Restless Legs Syndrome Market Size by Country (2018-2024) & (US$ Million)
Table 113. Middle East & Africa Restless Legs Syndrome Market Size by Country (2024-2034) & (US$ Million)
Table 114. Restless Legs Syndrome Market Trends
Table 115. Restless Legs Syndrome Market Drivers
Table 116. Restless Legs Syndrome Market Challenges
Table 117. Restless Legs Syndrome Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Restless Legs Syndrome Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Restless Legs Syndrome Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Restless Legs Syndrome Market Share by Regions: 2022 VS 2034
Figure 4. Global Restless Legs Syndrome Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Restless Legs Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Restless Legs Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Restless Legs Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Restless Legs Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Restless Legs Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Pharmacological Therapy
Figure 11. Global Pharmacological Therapy Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Non-Pharmacological Therapy
Figure 13. Global Non-Pharmacological Therapy Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Global Restless Legs Syndrome Market Size Share by Type: 2022 & 2034
Figure 15. North America Restless Legs Syndrome Revenue Market Share by Type (2018-2034)
Figure 16. Europe Restless Legs Syndrome Revenue Market Share by Type (2018-2034)
Figure 17. Asia-Pacific Restless Legs Syndrome Revenue Market Share by Type (2018-2034)
Figure 18. Latin America Restless Legs Syndrome Revenue Market Share by Type (2018-2034)
Figure 19. Middle East and Africa Restless Legs Syndrome Revenue Market Share by Type (2018-2034)
Figure 20. Below 35 Years Old Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 21. From 35 to 50 Years Old Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Above 50 Years Old Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. Global Restless Legs Syndrome Market Size Share by Application: 2022 & 2034
Figure 24. North America Restless Legs Syndrome Revenue Market Share by Application (2018-2034)
Figure 25. Europe Restless Legs Syndrome Revenue Market Share by Application (2018-2034)
Figure 26. Asia-Pacific Restless Legs Syndrome Revenue Market Share by Application (2018-2034)
Figure 27. Latin America Restless Legs Syndrome Revenue Market Share by Application (2018-2034)
Figure 28. Middle East and Africa Restless Legs Syndrome Revenue Market Share by Application (2018-2034)
Figure 29. Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Restless Legs Syndrome Market Share in 2022
Figure 31. North America Restless Legs Syndrome Market Share by Country (2018-2034)
Figure 32. United States Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 33. Canada Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 34. Germany Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 35. France Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 36. U.K. Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 37. Italy Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 38. Russia Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 39. Nordic Countries Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 40. Asia-Pacific Restless Legs Syndrome Market Share by Region (2018-2034)
Figure 41. China Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 42. Japan Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 43. South Korea Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 45. India Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 46. Australia Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 47. Latin America Restless Legs Syndrome Market Share by Country (2018-2034)
Figure 48. Mexico Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 49. Brazil Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Restless Legs Syndrome Market Share by Country (2018-2034)
Figure 51. Turkey Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 53. UAE Restless Legs Syndrome Market Size (2018-2034) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report